GUIDANT CONTAK RENEWAL FAMILY OF CARDIAC RESYNCHRONIZATION THERAPY DEVICES

Cardiac related image

A Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Related Image

(Not Necessarily related to the device)

Description:

GUIDANT CONTAK RENEWAL FAMILY OF CARDIAC RESYNCHRONIZATION THERAPY DEVICES by Boston Scientific Corp.

The Contak Renewal family of devices by Boston Scientific Corp. represents innovative, high-performance Cardiac Resynchronization Therapy Defibrillators (CRT-Ds). The primary use of these devices is to offer optimal heart rhythm management for patients suffering from moderate to severe heart failure.

These devices work by delivering small, imperceptible electrical impulses to both lower chambers of the heart, enabling them to beat together in a more synchronized pattern. This improved synchrony can significantly enhance heart function and overall patient wellbeing.

Beneath the impressive functionality, key benefits of the Guidant Contak Renewal range include:

Individualized Therapy: The devices can be customized to adapt to individual patient needs, delivering therapy as per the unique pathological requirements of each patient.

Improved Quality of Life: By reducing symptoms such as shortness of breath and fatigue associated with heart failure, these devices significantly enhance patients' physical functioning and quality of life.

Durability and Longevity: These devices are designed for durability with advanced battery technology, providing patients with reliable and long-lasting therapy.

Advanced Diagnostics: The Guidant Contak Renewal devices provide comprehensive diagnostic data which assists healthcare professionals in tracking disease progression and modifying treatment as required.

Primary Use:

GUIDANT CONTAK RENEWAL FAMILY OF CARDIAC RESYNCHRONIZATION THERAPY DEVICES: A Comprehensive Overview

Primary Medical Use
The Guidant Contak Renewal Family of Cardiac Resynchronization Therapy Devices, falling under the category of pacemakers, specializes in managing and regulating the synchronous contraction of the heart's chambers. Key Function
Essentially, these sophisticated devices optimize the synchronization between the left and right ventricles of the heart, facilitating better blood flow and oxygen distribution throughout the body. Beneficial Impact
They are highly beneficial for patients diagnosed with heart conditions that disrupt normal ventricular contractions, primarily heart failure and cardiomyopathy. Regularizing the

How It Works:

Understanding the Guidant Contak Renewal Family of Cardiac Resynchronization Therapy Devices

The GUIDANT CONTAK RENEWAL FAMILY OF CARDIAC RESYNCHRONIZATION THERAPY DEVICES under the category of 'pacemakers' offers a sophisticated suite of therapeutic applications built on a foundation of proven technology. The primary purpose of these devices is to correct cardiac dyssynchrony, a condition where the heart's chambers don't beat in synchronized rhythm. This dyssynchrony is a common complication in patients with advanced heart failure.

Technology and Mechanism of Action

Normal heart function and rhythm is the result of a carefully coordinated symphony of electrical impulses. When this coordination is disrupted, it can lead to inefficient pumping and worsening symptoms of heart failure, a condition addressed effectively by the Guidant Contak Renewal devices. At the heart of these devices is a novel technology known as Cardiac Resynchronization Therapy (CRT). CRT delivers small, timed electrical impulses to the heart's lower chambers (the ventricles), allowing them to beat synchronously again. This synchronization can significantly enhance cardiac function and performance in patients with advanced heart failure and conduction abnormalities such as left bundle branch block. This device uses Biventricular Pacing, where impulses are delivered to both ventricles simultaneously, thus maximizing synchronization and cardiac output.

Implementation and Patient Care

Effective delivery and optimization of therapy is a cornerstone feature of the GUIDANT CONTAK RENEWAL devices. The device has been engineered to provide the utmost flexibility, with multiple timing cycles and programmable parameters to individualize therapy and maximize patient response. On top of this, these devices have extensive arrhythmia management features and potent diagnostic capability. The integrated Heart Failure Disease Management tools provide physicians with comprehensive insights into their patients' physiological data, empowering them to make informed, timely therapeutic decisions. In conclusion, the GUIDANT CONTAK RENEWAL FAMILY OF CARDIAC RESYNCHRONIZATION THERAPY DEVICES offers a state-of-the-art solution for patients with advanced heart failure and conduction abnormalities, representing an essential tool in the armamentarium of contemporary pacing and electrophysiology.

Manufacturer:

Boston Scientific Corp.

Status: In Stock

Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.